Vivimed Labs Ltd (VIVIMEDLAB) Stock Analysis | Price, Returns, Financials & Key Metrics

Key Events This Week

4 May: Week opens at Rs.6.76

5 May: Rating upgraded to ‘Sell’ on technical improvements

7 May: Stock hits upper circuit at Rs.7.02 amid strong buying

8 May: Week closes at Rs.6.88, up 1.78%

Vivimed Labs Ltd Locks at Upper Circuit With 3.14% Gain — Buyers Queue, Sellers Absent

At Rs 7.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 3.14% on 7 May 2026, with buyers queuing and no sellers willing to part with shares.

Vivimed Labs Ltd Downgraded to Strong Sell Amid Weak Financials and Technical Deterioration

Vivimed Labs Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating fundamentals and a shift in technical indicators. The company’s micro-cap status, combined with weak financial trends and bearish technical signals, has prompted analysts to revise their outlook, signalling caution for investors amid ongoing challenges.

[ { "link": "quarterly", "btn_text": "All Quarterly Results", "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Dec'25", "", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "11.63", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "-11.22", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Interest", "val1": "0.94", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "-16.57", "val2": "NA", "chgp": "NA", "chgp_class": "neutral" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "-96.47%", "val2": "NA%", "chgp": "NA", "chgp_class": "neutral" } ] } }, { "link": "half-yearly", "btn_text": "All Half Yearly Results", "alert": "No Half Yearly Results declared by Vivimed Labs." }, { "link": "nine-monthly", "btn_text": "All Nine Monthly Results", "alert": "No Nine Monthly Results declared by Vivimed Labs." }, { "link": "annual", "btn_text": "All Annual Results", "header": "Annual Results Snapshot (Consolidated) - Mar'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "YoY Growth in year ended Mar 2025 is -37.86% vs -21.15% in Mar 2023", "dir": -1 }, { "prefix": "Consolidated Net Profit ", "suffix": "YoY Growth in year ended Mar 2025 is 90.27% vs -385.63% in Mar 2023", "dir": 1 } ], "table": { "header": [ "Mar'25", "Mar'23", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "116.27", "val2": "187.10", "chgp": "-37.86%", "chgp_class": "negative" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "-13.05", "val2": "-187.30", "chgp": "93.03%", "chgp_class": "positive" }, { "field": "Interest", "val1": "2.95", "val2": "35.90", "chgp": "-91.78%", "chgp_class": "positive" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Consolidate Net Profit", "val1": "-31.96", "val2": "-328.53", "chgp": "90.27%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "-11.22%", "val2": "-100.11%", "chgp": "88.89%", "chgp_class": "positive" } ] } } ]